Mon, 23rd Jun 2014 13:44
LONDON (Alliance News) - Hikma Pharmaceuticals PLC Monday said Chief Strategy and Corporate Development Officer Bassam Kanaan sold 49,476 shares at a price of GBP16.85 each Friday.
Following this transaction, Kanaan holds 454,090 shares.
Shares in the pharmaceutical company were down 0.8% at 1,674.00 pence Monday.
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun
Copyright 2014 Alliance News Limited. All Rights Reserved.
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:
(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth readi...
(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported an encouraging start to the year supported by all three business segments.
(Sharecast News) - Pharmaceuticals group Hikma said it has made a "strong and encouraging start" to 2024, with all three business segments performing ...
Hikma Pharmaceuticals (HIK)